References
Chan JK, Lamant L, Algar E et al (2008) ALK+ histiocytosis: a novel type of systemic histiocytic proliferative disorder of early infancy. Blood 112(7):2965–2968. https://doi.org/10.1182/blood-2008-03-147017
Chang KTE, Tay AZE, Kuick CH et al (2018) ALK-positive histiocytosis: an expanded clinicopathologic spectrum and frequent presence of KIF5B-ALK fusion. Mod Pathol 32(5):598–608. https://doi.org/10.1038/s41379-018-0168-6
Huang H, Gheorghe G, North PE, Suchi M (2018) Expanding the phenotype of ALK-positive histiocytosis: a report of 2 cases. Pediatr Dev Pathol 21(5):449–455. https://doi.org/10.1177/1093526617740784
Louis DN, Ohgaki H, Wiestler OD et al (2016) WHO Classification of Tumours of the Central Nervous System (revised 4th edition). International Agency for Research on Cancer (IARC), Lyon, France
Kline CN, Joseph NM, Grenert JP et al (2017) Targeted next-generation sequencing of pediatric neuro-oncology patients improves diagnosis, identifies pathogenic germline mutations, and directs targeted therapy. Neuro-oncology 19(5):699–709. https://doi.org/10.1093/neuonc/now254
Diamond EL, Durham BH, Haroche J et al (2016) Diverse and targetable kinase alterations drive histiocytic neoplasms. Cancer Discov 6(2):154–165. https://doi.org/10.1158/2159-8290.CD-15-0913
Estrada-veras JI, O'brien KJ, Boyd LC et al (2017) The clinical spectrum of Erdheim–Chester disease: an observational cohort study. Blood Adv 1(6):357–366. https://doi.org/10.1182/bloodadvances.2016001784
Yoshihara K, Wang Q, Torres-garcia W et al (2015) The landscape and therapeutic relevance of cancer-associated transcript fusions. Oncogene 34(37):4845–4854. https://doi.org/10.1038/onc.2014.406
Acknowledgements
D.A.S is supported by NIH Director’s Early Independence Award (DP5 OD021403). We thank the staff of the UCSF Clinical Cancer Genomics Laboratory for assistance with genetic profiling.
Author information
Authors and Affiliations
Corresponding author
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Lucas, CH.G., Gilani, A., Solomon, D.A. et al. ALK-positive histiocytosis with KIF5B-ALK fusion in the central nervous system. Acta Neuropathol 138, 335–337 (2019). https://doi.org/10.1007/s00401-019-02027-7
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00401-019-02027-7